Vistin Pharma — Share Issue/Capital Change 2015

Jun 2, 2015

Trading period for the subscription rights will end today at 16:30 CET

Trading period for the subscription rights will end today at 16:30 CET

(This is a copy of announcement from Weifa ASA,

02.06.2015 at 07:30 hours.)

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN

WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN

AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES

Oslo, Norway, 2 June 2015

Weifa ASA (OSE: WEIFA), reference is made to the

stock exchange announcement by Weifa ASA ("Weifa")

on 26 May 2015 regarding approved prospectus for

Vistin Pharma ASA (the "Company") and commencement

of the subscription period in the Rights Offering of

15,554,935 new shares at a subscription price of NOK

The trading period for the subscription rights

(ticker: VISTIN T) will end today, 2 June 2015 at

16:30 CET.

Any subscription right not sold prior to 16:30 CET

today, 2 June 2015, or not used to subscribe for New

Shares in the Rights Offering prior to 16:30 CET on 4

June 2015 will lapse and cease to carry any value.

The Prospectus together with the Subscription Form

is available at www.weifa.no and www.carnegie.no,

and is also available free of charge at the

business offices of the Company (Østensjøveien 27,

0661 Oslo) and Carnegie (Grundingen 2, Aker Brygge,

0106 Oslo). Norwegian investors with a VPS

account can in addition subscribe for New

Shares in the Rights Offering online at

www.carnegie.no.

Contact:

Gunnar Manum

CFO

+47 951 79 190

gunnar.manum@weifa.no

This information is subject to the disclosure

requirements pursuant to section 5-12 of the

Norwegian Securities Trading Act.

Important information:

The release is not for publication or distribution,

in whole or in part directly or indirectly, in or

into Australia, Canada, Japan or the United

States (including its territories and possessions,

any state of the United States and the District of

Columbia).

This release is an announcement issued

pursuant to legal information obligations, and is

subject of the disclosure requirements pursuant to

section 5-12 of the Norwegian Securities Trading

Act. It is issued for information purposes only, and

does not constitute or form part of any offer or

solicitation to purchase or subscribe for

securities, in the United States or in any other

jurisdiction. The securities mentioned herein have

not been, and will not be, registered under the

United States Securities Act of 1933, as amended

(the "Securities Act"). The securities may not be

offered or sold in the United States except

pursuant to an exemption from the registration

requirements of the Securities Act. The Company

does not intend to register any portion of the

offering of the securities in the United States or

to conduct a public offering of the securities in

the United States. Copies of this announcement are

not being made and may not be distributed or sent

into Australia, Canada, Japan or the United States.

The issue, exercise, purchase or sale of subscription

rights and the subscription or purchase of

shares in the Company are subject to specific

legal or regulatory restrictions in certain

jurisdictions. Neither the Company nor the Manager

assumes any responsibility in the event there is a

violation by any person of such restrictions.

The distribution of this release may in certain

jurisdictions be restricted by law. Persons into

whose possession this release comes should inform

themselves about and observe any such

restrictions. Any failure to comply with these

restrictions may constitute a violation of the

securities laws of any such jurisdiction. Carnegie

is acting for the Company and no one else in

Connection with the Offering and will not be

responsible to anyone other than the Company

for providing the protections afforded to

their respective clients or for providing advice in

relation to the Offering and/or any other matter

referred to in this release.

***